Comparison of PENG Block and FICB in Hip Fracture Patients

March 21, 2022 updated by: Hajung Kim, Asan Medical Center

Comparison of Analgesic Effect of Pericapsular Nerve Group Block and Suprainguinal Fascia Iliaca Compartment Block on Dynamic Pain in Patients Undergoing Hip Fracture Surgery: a Randomized Controlled Trial

Fascia iliaca compartment block (FICB) has been considered the block of choice for patients with hip fracture. However, pericapsular nerve group (PENG) block, one of the relatively newly-developed blocks, could be also used for analgesia in patients with hip fracture. Since PENG block could block the accessory obturator nerve, PENG block might have greater analgesic effects compared to FICB theoretically. However, the comparison of these two blocks in patients with hip fracture has not performed in clinical setting. Thus, we aimed to compare the analgesic effect of PENG block and FICB.

Study Overview

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • ASA PS 1-4
  • age: ≥19
  • baseline pain score (associated with hip fracture): ≥4

Exclusion Criteria:

  • patients who do not agree to participate in this study
  • patients with uncontrolled hypertension, hyperthyroidism, severe dementia
  • allergic to ropivacaine
  • contraindicated to spinal anesthesia due to coagulopathy, severe aortic stenosis/mitral stenosis, or active infection on lumbar region
  • patients who are considered ineligible with any other reason by investigators

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: PENG group
pericapsular nerve group (PENG) block before surgery
ultrasound-guided PENG block with 0.3% ropivacaine 20cc
Active Comparator: FICB group
suprainguinal fascia iliaca compartment block (FICB) before surgery
ultrasound-guided suprainguinal FICB with 0.3% ropivacaine 30cc

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Efficacy of each block (Pain score)
Time Frame: before surgery

We will assess the dynamic pain (pain during a movement) using NRS before and 20-30min after applying the assigned block. Then, we will calculate the change of NRS at the two time-points.

NRS: Numerical rating scale (0, no pain; 10, the worst pain imaginable)

before surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change of blood pressure (systolic, diastolic, mean blood pressure)
Time Frame: before surgery
We will evaluate the blood pressure before and 20-30min after applying the assigned block. Then, we will calculate the change of blood pressure at the two time-points.
before surgery
postoperative pain score
Time Frame: postoperative 6, 24, 48hours

resting and dynamic pain using NRS at postoperative 6, 24, 48hours

NRS: Numerical rating scale (0, no pain; 10, the worst pain imaginable)

postoperative 6, 24, 48hours
postoperative opioid consumption
Time Frame: postoperative 24, 48hours
morphine-equivalent dose
postoperative 24, 48hours
postoperative motor function
Time Frame: postoperative 6, 24, 48hours

motor function of quadriceps femoris

grade5: normal power grade4: movement possible against some resistance grade3: movement against gravity but not resistance grade2: movement possible if gravity eliminated grade1: flicker of contraction possible grade0: complete paralysis

postoperative 6, 24, 48hours
change of heart rate
Time Frame: before surgery
We will evaluate the heart rate before and 20-30 min after applying the assigned block. Then, we will calculate the change of heart rate at the two time-points.
before surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Won Uk Koh, MD, PhD, Asan Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 21, 2021

Primary Completion (Actual)

January 26, 2022

Study Completion (Actual)

February 11, 2022

Study Registration Dates

First Submitted

December 10, 2020

First Submitted That Met QC Criteria

December 15, 2020

First Posted (Actual)

December 21, 2020

Study Record Updates

Last Update Posted (Actual)

March 23, 2022

Last Update Submitted That Met QC Criteria

March 21, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Fractures

Clinical Trials on Pericapsular nerve group (PENG) block

Subscribe